Rating History for Theriva Biologics (TOVX) by Maxim Group
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/31/2026 | Jason McCarthy | Upgrade | Buy (Hold) |
1.00 (N/A) |
0.19 (0.24) |
26.32% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/31/2026 | Jason McCarthy | Upgrade | Buy (Hold) |
1.00 (N/A) |
0.19 (0.24) |
26.32% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||